Sanara MedTech Inc.
SMTI- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0000714256
No open-market purchases or sales by Sanara MedTech Inc. insiders were filed in the last 90 days; 74 institutions reported holding it in 13F filings for Q2 2026, worth $42.1M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Sanara MedTech Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −1 vs. Q3 2021
- Shares held
- 342.1K
- −40.4K (−10.6%) vs. Q3 2021
- Total value
- $10.2M
- −$2.89M (−22.1%) vs. Q3 2021
- New holders
- 3
- 10 more added
- Sold out
- 4
- 3 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SMTI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 74 | $42.1M |
| Q1 2026 | 65 | $25.6M |
| Q4 2025 | 53 | $45.2M |
| Q3 2025 | 58 | $36.1M |
| Q2 2025 | 53 | $31.4M |
| Q1 2025 | 49 | $28.3M |
| Q4 2024 | 51 | $31.6M |
| Q3 2024 | 44 | $24.5M |
| Q2 2024 | 40 | $20.6M |
| Q1 2024 | 43 | $25.1M |
| Q4 2023 | 47 | $28.2M |
| Q3 2023 | 43 | $19.8M |
| Q2 2023 | 47 | $26.7M |
| Q1 2023 | 35 | $19.1M |
| Q4 2022 | 31 | $17.4M |
| Q3 2022 | 28 | $9.94M |
| Q2 2022 | 21 | $5.45M |
| Q1 2022 | 21 | $7.79M |
| Q4 2021 | 23 | $10.2M |
| Q3 2021 | 24 | $13.1M |
| Q2 2021 | 21 | $9.72M |
| Q1 2021 | 20 | $17.2M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Sanara MedTech Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 92,511 | $2.73M | 0.00% | +7,933+9.4% | Added |
| North Run Capital, LP | 65,000 | $1.92M | 1.48% | +8,811+15.7% | Added |
| Diametric Capital, LP | 29,362 | $868.0K | 0.66% | +8,153+38.4% | Added |
| Laurion Capital Management LP | 25,047 | $762.0K | 0.01% | −2,977−10.6% | Reduced |
| Geode Capital Management, LLC | 24,583 | $747.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 16,800 | $511.0K | 0.00% | +3,900+30.2% | Added |
| Prelude Capital Management, LLC | 17,223 | $509.0K | 0.03% | +4,300+33.3% | Added |
| Captrust Financial Advisors | 14,768 | $436.0K | 0.00% | +14,768 | New |
| Salem Investment Counselors Inc | 11,210 | $331.0K | 0.01% | 00.0% | Unchanged |
| Anson Funds Management LP | 9,097 | $269.0K | 0.04% | +9,097 | New |
| BlackRock Inc. | 8,328 | $247.0K | 0.00% | +301+3.7% | Added |
| State Street Corp | 7,400 | $225.0K | 0.00% | 00.0% | Unchanged |
| New York State Common Retirement Fund | 5,747 | $175.0K | 0.00% | −14,242−71.2% | Reduced |
| Morgan Stanley | 5,672 | $167.0K | 0.00% | +1,421+33.4% | Added |
| Rockefeller Capital Management L.P. | 4,500 | $132.0K | 0.00% | 00.0% | Unchanged |
| Commons Capital, LLC | 2,043 | $60.0K | 0.06% | +2,043 | New |
| Lazard Asset Management LLC | 1,143 | $34.0K | 0.00% | +67+6.2% | Added |
| UBS Group AG | 905 | $27.0K | 0.00% | +330+57.4% | Added |
| Lee Financial Co | 500 | $15.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 123 | $4.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 50 | $1.00K | 0.00% | −96−65.8% | Reduced |
| Bank of America Corp | 28 | $1.00K | 0.00% | +22+366.7% | Added |
| Wells Fargo & Company | 16 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 0 | $0 | 0.00% | −68,215−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −5,997−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |